CERN’s federated learning platform, CAFEIN*, which was originally designed to spot anomalies in the operation of the accelerator chain, can also be used in healthcare, specifically in the management of stroke patients.

Vall d'Hebron, a leading healthcare campus in Barcelona, CERN and eleven other partners from across Europe have joined forces to assist clinicians, caregivers and patients by creating AI algorithms using data confined to the hospital environment – the key feature of the CAFEIN platform. Read more about this new EU project, called TRUSTroke**, in this article.

You are warmly invited to attend this seminar and learn about this example of how CERN technologies can have societal impact and change our lives.

The seminar will be given by Luigi Serio (CERN) and Pietro Caliandro (Policlinico Gemelli), with an introduction by Mike Lamont, CERN’s Director for Accelerators and Technology.

More information: https://indico.cern.ch/e/trustroke .

------

* The Computer-Aided deFEcts detection, Identification and classificatioN (CAFEIN) project has received support from the CERN Budget for knowledge transfer to medical applications through a grant awarded in 2019.

**The TRUSTroke project is funded by the European Union in the call HORIZON-HLTH-2022-STAYHLTH-01-two-stage, under grant agreement No-101080564